New algorithm aims to speed up diagnosis of mysterious high white blood cell counts
NCT ID NCT02581514
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a decision algorithm to help doctors diagnose the cause of eosinophilia (high levels of a type of white blood cell). The algorithm guides which tests to do and in what order. Researchers enrolled 53 patients and measured how many followed the algorithm correctly, how often a diagnosis was made, and how long it took. The goal is to make diagnosis faster and more efficient.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If the algorithm works well, it could help doctors diagnose the cause of high eosinophil levels more quickly and with fewer tests.
- What could go wrong
- This is a small, completed study (53 people) testing a diagnostic process, not a treatment. The algorithm may not work for everyone or in other hospitals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPEREOSINOPHILIC SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Médecine Interne A
Limoges, 87000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists launch national effort to unravel mysteries of rare blood disorder
- Drug dasatinib tested for rare blood cancers
- New clues to spot a rare blood disorder
- New hope for rare blood disorder: drug targets overactive immune cells
- New drug aims to tame rare blood disorder flares
- New hope for kids with rare blood disorder: drug may cut flares and steroid use